However, Sasako et al. showed that interfering with the insulin/IGF-1 signaling pathway by suppressing Akt activity in mouse skeletal muscle can accelerate sarcopenia and reduce lifespan, a phenomenon reversed by deactivating FoxOs rather than activating mTOR (59). This evidence concerns the gene IGF1 and sarcopenia.